[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"]
- PMID: 24450113
[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"]
Abstract
The neuropathological characteristics of the Alzheimer's disease (AD) brain include senile plaques, neurofibrillary tangles and neuronal cell loss extensively recognized in brain cortices. Biochemical studies revealed that senile plaques and neuronfibrillary tangles are composed mainly of amyloid beta protein and highly phosphorylated tau protein, a microtubule-associated protein, respectively. Abeta deposition in senile plaques was previously considered to initiate the pathological cascade of Alzheimer's disease (AD), suggesting that the aggregation of Abeta in insoluble Abeta fibrils plays an important role in its neurotoxicity ('amyloid cascade hypothesis'). However, the concentrations of Abeta required for fibrillization are higher than its physiological concentrations. In addition, cognitive decline in AD patients is not correlated with the levels of senile plaque formation. Currently, AD is believed to begin with synaptic dysfunction caused by soluble Abeta oligomers, playing a more important role in the etiology of AD than insoluble Abeta ibrils ('oligomer hypothesis').
Similar articles
-
[Involvement of beta-amyloid in the etiology of Alzheimer's disease].Brain Nerve. 2010 Jul;62(7):691-9. Brain Nerve. 2010. PMID: 20675873 Review. Japanese.
-
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847. JAMA Neurol. 2014. PMID: 24493463 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Alzheimer's disease and amyloid: culprit or coincidence?Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Int Rev Neurobiol. 2012. PMID: 22748834 Review.
-
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.Brain. 2014 Mar;137(Pt 3):887-903. doi: 10.1093/brain/awt362. Epub 2014 Feb 10. Brain. 2014. PMID: 24519982
Cited by
-
Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer's disease.Neural Regen Res. 2015 Mar;10(3):365-7. doi: 10.4103/1673-5374.153679. Neural Regen Res. 2015. PMID: 25878578 Free PMC article. No abstract available.
-
Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.Neurochem Res. 2017 Dec;42(12):3446-3455. doi: 10.1007/s11064-017-2391-9. Epub 2017 Aug 24. Neurochem Res. 2017. PMID: 28836062
-
Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.Antioxid Redox Signal. 2015 May 1;22(13):1188-206. doi: 10.1089/ars.2014.6126. Epub 2014 Nov 11. Antioxid Redox Signal. 2015. PMID: 25275222 Free PMC article. Review.
-
Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease.PLoS One. 2015 Jun 5;10(6):e0128553. doi: 10.1371/journal.pone.0128553. eCollection 2015. PLoS One. 2015. PMID: 26046986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical